Stuttgart - Delayed Quote EUR

Novozymes A/S (NZM2.SG)

58.22
-0.28
(-0.48%)
At close: May 13 at 8:14:41 AM GMT+2
Loading Chart for NZM2.SG
  • Previous Close 58.50
  • Open 58.16
  • Bid 58.68 x 50000
  • Ask 59.02 x 50000
  • Day's Range 58.16 - 58.22
  • 52 Week Range 50.10 - 64.92
  • Volume 0
  • Avg. Volume 99
  • Market Cap (intraday) 17.489B
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) 40.26
  • EPS (TTM) 1.45
  • Earnings Date May 8, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Novozymes A/S produces and sells industrial enzymes, microorganisms, and biopolymers worldwide. It operates through three divisions: Household Care and Technical Industries, Agriculture and Bioenergy, and Food and Beverages. The company offers solutions for the agriculture industry, including enzymes for animal nutrition to enhance digestion processes; probiotics; microbial solutions to maintain water quality that limits risk of disease and enhances yields in aquaculture; and microbial-based biocontrol and bioyield enhancer products to naturally produce healthier crops and enhance yields. It also provides a portfolio of enzymes for application in biofuel production; enzymes for drug delivery and drug formulation; and food and beverages enzymes for applications in baking, brewing, dairy, distilling, flavor enhancement, food specialties, health and nutrition, juice, meat processing, oils and fats, starch, and wine industries. In addition, the company offers household care enzyme and microbial agents for use in cleaning solutions, dishwashing, and laundry; enzymes for biopreparation, degreasing, and re-bating of leather; enzymes for pulp and paper production processes, such as bleach boosting, deinking, drainage enhancement, effluent control, pitch control, refining, slime control, starch modification, and stickies control; enzymatic solutions for processing textiles; and biological wastewater treatment products. Novozymes A/S has a strategic alliance with Monsanto Company to discover, develop, and sell microbial solutions for farmers. The company was founded in 1925 and is headquartered in Bagsvaerd, Denmark.

www.novozymes.com

6,385

Full Time Employees

December 31

Fiscal Year Ends

--

Sector

--

Industry

Recent News: NZM2.SG

View More

Performance Overview: NZM2.SG

Trailing total returns as of 5/13/2025, which may include dividends or other distributions. Benchmark is OMX Copenhagen 25 Index (^OMXC25) .

YTD Return

NZM2.SG
15.64%
OMX Copenhagen 25 Index (^OMXC25)
5.18%

1-Year Return

NZM2.SG
16.19%
OMX Copenhagen 25 Index (^OMXC25)
0.00%

3-Year Return

NZM2.SG
31.32%
OMX Copenhagen 25 Index (^OMXC25)
6.31%

5-Year Return

NZM2.SG
144.52%
OMX Copenhagen 25 Index (^OMXC25)
33.70%

Compare To: NZM2.SG

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: NZM2.SG

View More

Valuation Measures

Annual
As of 5/12/2025
  • Market Cap

    27.25B

  • Enterprise Value

    28.70B

  • Trailing P/E

    59.09

  • Forward P/E

    28.99

  • PEG Ratio (5yr expected)

    0.25

  • Price/Sales (ttm)

    6.76

  • Price/Book (mrq)

    2.43

  • Enterprise Value/Revenue

    7.07

  • Enterprise Value/EBITDA

    34.98

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    20.90%

  • Return on Assets (ttm)

    13.79%

  • Return on Equity (ttm)

    26.46%

  • Revenue (ttm)

    2.12B

  • Net Income Avi to Common (ttm)

    443.42M

  • Diluted EPS (ttm)

    1.45

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    107.64M

  • Total Debt/Equity (mrq)

    16.85%

  • Levered Free Cash Flow (ttm)

    232.8M

Research Analysis: NZM2.SG

View More

Company Insights: NZM2.SG

Research Reports: NZM2.SG

View More